3.7 Infliximab and ustekinumab A Phase 2 trial (NCT06453317) compares infliximab and ustekinumab monoclonal antibodies individually versus their combination in treating moderate to severe UC, with the primary outcome measuring clinical and endoscopic remission rates after induction therapy at weeks 14-16
Here's what you need to know: Employer-sponsored plans only cover Zepbound if the employer specifically added weight management drug benefits [1] Individual/Marketplace plans typically exclude weight loss medications entirely Medicare Advantage does not cover Zepbound for weight loss see our Medicare coverage guide for details and workarounds [2] Optum Rx (UHC's pharmacy benefit manager) places Zepbound in high-cost specialty tiers when covered Bottom line: Don't assume your UHC plan covers Zepbound
M.BurrisH.JankuF.MirO.et al
[23] Kudos to the team at The Vitamin Shoppe for bringing this one out -- glutamic acid is a lesser-known gem that we had just begun digging into, and the research looks quite promising
Constipation lasting more than three days without bowel movement, especially if accompanied by severe bloating or abdominal distension, warrants medical consultation
HUM offers two standout supplements, both designed to support metabolic health and boost GLP-1 levels: Best of Berberine Berberine is a powerful plant compound shown to support insulin sensitivity, helps maintain healthy blood sugar levels, and promote a healthy metabolism